Clonazepam for the Treatment of Panic Disorder
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Clonazepam was initially licensed as an anti-epileptic agent, but its use in a wide variety of psychiatric conditions, including panic disorder (PD) has now been well established. This overview evaluates the current role of clonazepam alone or in combination with antidepressants and/or behavioral therapy in the treatment of PD. We review the data establishing the use of clonazepam in the treatment of PD as well as new information, particularly confirmation of longterm efficacy and safety. We also discuss a regimen for safely tapered withdrawal of clonazepam, the characteristics of the respiratory subtype of PD, and CO2-induced panic attacks as a diagnostic measure and predictor for therapeutic success. It has been shown that panic attacks can more readily be induced by CO2 in PD patients with the respiratory subtype than those with the non-respiratory subtype. More than 25 years after the first report of efficacy in PD in 1984, clonazepam, alone or combined with selective serotonin reuptake inhibitors (SSRIs) and/or behavioral therapy, remains an important therapeutic modality for the management of PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quality of Life in Individuals With Anxiety Disorders
Mendlowicz, M. V., & Stein, M. B. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.669 · Cited by 955 · cited 1×
“PD is a frequent and debilitating psychiatric condition associated with reduced quality of life [21-24], and impaired work performance [24, 25].”
BackgroundKessler, R. C., Chiu, W. T., Jin, R., Ruscio, A. M., Shear, K., & Walters, E. E. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.4.415 · Cited by 795 · cited 2×
“It is also hypothesized that disturbances of the acid-base balance in the brainstem may play a role in the pathogenesis of PD [14, 31].”
BackgroundA cross-ethnic comparison of lifetime prevalence rates of anxiety disorders
Asnaani, A., Richey, J. A., Dimaite, R., Hinton, D. E., & Hofmann, S. G. (2010) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0b013e3181ea169f · Cited by 331 · cited 1×
“prevalence rates differ considerably between racial groups, with white Americans more likely to be diagnosed with PD than African Americans [33].”
BackgroundAntidepressant-Induced Sexual Dysfunction
Gregorian, R. S., Golden, K. A., Bahce, A., Goodman, C., Kwong, W. J., & Khan, Z. M. (2002) · Annals of Pharmacotherapy · doi:10.1345/aph.1a195 · Cited by 320 · cited 2×
“While no paper reported any serious AEs associated with clonazepam, there were a few reports of patients discontinuing clonazepam therapy due to tolerability problems, such as sedation, sleep disturbances, and/or nausea [62, 64, 71].”
BackgroundGrant, B. F., Hasin, D. S., Stinson, F. S., Dawson, D. A., Goldstein, R. B., Smith, S., Huang, B., & Saha, T. D. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0305 · Cited by 258
Panic disorder and control of breathing
Nardi, A. E., Freire, R. C., & Zin, W. A. (2009) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2008.07.011 · Cited by 151
Self-citationCarbon dioxide/oxygen challenge test in panic disorder
Perna, G., Battaglia, M., Garberi, A., Arancio, C., Bertani, A., & Bellodi, L. (1994) · Psychiatry Research · doi:10.1016/0165-1781(94)90085-x · Cited by 142
Hyperventilation in panic disorder and asthma: Empirical evidence and clinical strategies
Meuret, A. E., & Ritz, T. (2010) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2010.05.006 · Cited by 118 · cited 1×
“of breath resembling the known symptoms of acute cardiac events are common [26, 27].”
BackgroundAntidepressant-Induced Sexual Dysfunction among Newer Antidepressants in a Naturalistic Setting
Lee, K.-U., Lee, Y. M., Nam, J.-M., Lee, H.-K., Kweon, Y.-S., Lee, C. T., & Jun, T.-Y. (2010) · Psychiatry Investigation · doi:10.4306/pi.2010.7.1.55 · Cited by 63 · cited 1×
“Published studies suggest that between 30% and 60% of patients receiving antidepressants including SSRIs may experience some form of treatment-induced sexual dysfunction [71-73].”
BackgroundNardi, A. E., Freire, R. C., Mochcovitch, M. D., Amrein, R., Levitan, M. N., King, A. L., Valença, A. M., Veras, A. B., Paes, F., Sardinha, A., et al. (2012) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31823fe4bd · Cited by 56 · cited 1×
“In recent years, long-term results for treating PD with benzodiazepines have become available, allowing a more fact-based choice of drug treatment for PD [14, 15].”
BackgroundSelf-citation
Cited by
Leigh, H. (2015) · Handbook of Consultation-Liaison Psychiatry · doi:10.1007/978-3-319-11005-9_14 · Cited by 309
Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications
Cosci, F., & Chouinard, G. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000506868 · Cited by 265
Self-citationBrandt, J., Bressi, J., Lê, M.-L., Neal, D., Cadogan, C., Witt-Doerring, J., Witt-Doerring, M., & Wright, S. (2024) · eClinicalMedicine · doi:10.1016/j.eclinm.2024.102507 · Cited by 77
Risks and benefits of medications for panic disorder: A comparison of SSRIs and benzodiazepines
Quagliato, L. A., Freire, R. C., & Nardi, A. E. (2018) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2018.1429403 · Cited by 62
Panic disorder respiratory subtype: psychopathology and challenge tests – an update
Okuro, R. T., Freire, R. C., Zin, W. A., Quagliato, L. A., & Nardi, A. E. (2020) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2019-0717 · Cited by 23
Self-citation
Metadata
- Authors
- E. Nardi, A., Machado, S., Ferreira Almada, L., Paes, F., Cardoso Silva, A., Jose Marques, R., Amrein, R., C. Freire, R., Martin-Santos, R., Cosci, F., E. Hallak, J., A. Crippa, J., & Arias-Carrion, O.
- Venue
- Current Drug Targets
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2013-01-01
- Volume
- 14
- Issue
- 3
- Pages
- 353-364
- ISSN
- 1389-4501 (ISSN-L)
- OpenAlex
- W2166964750
- Cited by
- 40
- References
- 13
- FWCI
- 3.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clonazepam for the Treatment of Panic Disorder. https://app.cochat.ai/papers/10.2174/1389450111314030007
- The paper
- E. Nardi, A., Machado, S., Ferreira Almada, L., Paes, F., Cardoso Silva, A., Jose Marques, R., Amrein, R., C. Freire, R., Martin-Santos, R., Cosci, F., E. Hallak, J., A. Crippa, J., & Arias-Carrion, O. (2013). Clonazepam for the Treatment of Panic Disorder. Current Drug Targets. https://doi.org/10.2174/1389450111314030007
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.